PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0221505|brain lesions |
| Sentences | 2 |
| PubMedID- 25853014 | Cu-dota-trastuzumab pet could be a potential noninvasive procedure for serial identification of metastatic brain lesions in patients with her2-positive breast cancer. |
| PubMedID- 24625110 | Several risk factors have been associated with the development of brain lesions in patients with metastatic breast cancer (mbc), including a younger age , negative estrogen receptor (er) status , human epidermal growth factor receptor 2-positive (her2+) disease , and brca1/2 mutation . |
Page: 1